President Donald Trump has made the search for finding a “cure” for autism a centerpiece of his public health agenda. This week he shared major developments in that effort.

On Monday, the Trump administration announced that the Food and Drug Administration would be adding a warning label to Tylenol and similar drugs that contain acetaminophen. Trump has suggested a connection between the widely used medication and autism. The president also promoted the drug leucovorin as a potential treatment for autism.

The announcement has led to confusion among many people about autism and the safety of Tylenol during pregnancy.

Joining “Post Reports” today to sift through this confusion is Washington Post White House reporter Dan Diamond. He and host Elahe Izadi also discuss what led to this announcement, what the Trump administration could do next and who pregnant patients should be turning to for health care.

Today’s episode was produced by Rennie Svirnovskiy, with help from Lucas Trevor. It was mixed by Sam Bair and edited by Elana Gordon. Thanks to Sabrina Malhi, Akilah Johnson, Ariana Eunjung Cha and Lynh Bui.

Subscribe to The Washington Post here.

The confusion over Tylenol, pregnancy and autism

Post Reports